Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

EW

Edwards Lifesciences Corp

May 02 • 04:00PM ET

85.06

Dollar change +0.76
Percentage change 0.90	%

Healthcare • Medical Devices • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VUG IVV IHI VHT IWF QUAL RSP VV

Index	S&P 500	P/E	36.56	EPS (ttm)	2.33	Insider Own	1.58%	Shs Outstand	601.10M	Perf Week	-3.35%
Market Cap	51.26B	Forward P/E	27.32	EPS next Y	3.11	Insider Trans	-4.63%	Shs Float	593.08M	Perf Month	-8.56%
Income	1.41B	PEG	3.92	EPS next Q	0.70	Inst Own	82.52%	Short Float	1.24%	Perf Quarter	8.07%
Sales	6.14B	P/S	8.34	EPS this Y	10.39%	Inst Trans	-0.08%	Short Ratio	1.88	Perf Half Y	33.49%
Book/sh	11.82	P/B	7.20	EPS next Y	12.35%	ROA	15.38%	Short Interest	7.38M	Perf Year	-3.13%
Cash/sh	2.82	P/C	30.13	EPS next 5Y	9.34%	ROE	21.59%	52W Range	60.57 - 96.12	Perf YTD	11.55%
Dividend Est.	-	P/FCF	188.86	EPS past 5Y	15.35%	ROI	18.14%	52W High	-11.51%	Beta	1.12
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	10.28%	Gross Margin	76.11%	52W Low	40.43%	ATR (14)	2.09
Dividend Ex-Date	-	Current Ratio	3.75	EPS Y/Y TTM	-3.43%	Oper. Margin	27.71%	RSI (14)	37.13	Volatility	2.76% 2.32%
Employees	19800	Debt/Eq	0.10	Sales Y/Y TTM	11.68%	Profit Margin	23.01%	Recom	2.12	Target Price	95.95
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	4.50%	Payout	0.00%	Rel Volume	0.50	Prev Close	84.30
Sales Surprise	1.80%	EPS Surprise	2.66%	Sales Q/Q	9.50%	Earnings	Apr 25 AMC	Avg Volume	3.92M	Price	85.06
SMA20	-4.11%	SMA50	-5.49%	SMA200	8.31%	Trades		Volume	1,942,853	Change	0.90%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102
Mar-29-23	Initiated	UBS	Neutral	$84
Mar-08-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $78
Feb-06-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-31-23	Downgrade	Bernstein	Outperform → Underperform	$95 → $66
Jan-30-23	Downgrade	Piper Sandler	Overweight → Neutral	$95 → $80
Dec-06-22	Downgrade	Stifel	Buy → Hold	$95 → $75
Oct-28-22	Downgrade	Oppenheimer	Outperform → Perform
Oct-26-22	Initiated	Mizuho	Buy	$100
Oct-18-22	Initiated	Barclays	Overweight	$96
Oct-12-22	Initiated	Jefferies	Buy	$110
Jul-29-22	Downgrade	Canaccord Genuity	Buy → Hold	$115 → $106
Apr-13-22	Initiated	Truist	Buy	$145

Show Previous Ratings

May-01-24 05:27PM	Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing (MT Newswires)
09:40AM	Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year? (Zacks)
09:35AM	Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW) (Zacks)
Apr-30-24 05:03PM	Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing (MT Newswires)
10:20AM	Edwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:22PM	Loading…
Apr-29-24 02:22PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:18PM	Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends (Zacks)
07:23AM	Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 (MT Newswires)
Apr-26-24 04:09PM	This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss (Investor's Business Daily)
11:21AM	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 (MT Newswires)
11:09AM	Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up (Zacks)
10:54AM	Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 (MT Newswires)
10:42AM	UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating (MT Newswires)
10:38AM	Q1 2024 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
10:29AM	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85 (MT Newswires)
09:53AM	Loading…
09:53AM	Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86 (MT Newswires)
08:28AM	Edwards gets Q1 boost as Pascal valve repair sales ramp up (MedTech Dive)
03:40AM	Edwards Lifesciences Corp (EW) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-25-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics (Zacks)
05:52PM	Edwards Lifesciences Q1 Earnings: Mixed Results with Adjusted EPS Beating Estimates (GuruFocus.com)
05:30PM	Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates (Zacks)
05:04PM	Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff (Investor's Business Daily)
04:34PM	Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set (MT Newswires)
04:26PM	Edwards Lifesciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports First Quarter Results (Business Wire)
Apr-23-24 06:14AM	Boston Scientific, Dexcom and Edwards next as earnings season rolls on (MedTech Dive)
Apr-22-24 09:16AM	Unveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Apr-19-24 01:08AM	Spinoffs, sales and tuck-ins top medtech deal priorities: Moodys (MedTech Dive)
Apr-18-24 10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
07:10AM	Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 (Business Wire)
11:01AM	Loading…
Apr-17-24 11:01AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings? (Zacks)
Apr-12-24 04:37AM	Abbotts Nadim Geloo on Triclips US launch, Edwards competition (MedTech Dive)
Apr-07-24 04:30PM	Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It (Business Wire)
Mar-26-24 08:02AM	14 Best Medical Device Stocks To Buy Now (Insider Monkey)
Mar-25-24 09:40AM	Are Medical Stocks Lagging Edwards Lifesciences (EW) This Year? (Zacks)
Mar-19-24 02:24PM	Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark (Investor's Business Daily)
01:38PM	Edwards Lifesciences (EW) Up 21.8% YTD: What's Driving It? (Zacks)
Mar-15-24 04:02PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:50AM	Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It? (Zacks)
Mar-13-24 11:57AM	Edwards Lifesciences' (EW) SAPIEN TAVR Study Outcome Favorable (Zacks)
Mar-11-24 02:00PM	Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR (Business Wire)
Mar-07-24 04:57PM	S&P 500 Gains and Losses Today: Index Notches Record Close Ahead of Jobs Report (Investopedia) +6.20%
11:31AM	Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-06-24 09:43AM	Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth (Zacks)
Feb-26-24 11:54AM	Here's Why You Should Buy Edward Lifesciences (EW) Stock Now (Zacks)
Feb-23-24 07:05AM	Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference (Business Wire)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 09:36AM	Edwards (EW) Gains From Balanced Core Growth and New Launches (Zacks)
Feb-13-24 12:09AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
Feb-09-24 02:21AM	Edwards Lifesciences Corp Director Heisz Stone Sells 7,056 Shares (GuruFocus.com)
Feb-07-24 04:11PM	Edwards Lifesciences' Fortunes Are Reaccelerating, Analyst Says But Its Stock Isn't (Investor's Business Daily)
11:19AM	Edwards Lifesciences Corporation (NYSE:EW) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:31AM	Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip (Zacks)
09:06AM	Q4 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
05:54AM	How Edwards Evoque valve won an early nod from the FDA (MedTech Dive)
Feb-06-24 07:55PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Edwards Lifesciences (EW) Q4 Earnings Match Estimates (Zacks)
04:54PM	Edwards Lifesciences Corp (EW) Reports Robust Q4 and Full-Year 2023 Financial Results (GuruFocus.com)
04:44PM	Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat (Investor's Business Daily)
04:40PM	Edwards Lifesciences: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Fourth Quarter Results (Business Wire)
07:18AM	Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System (Zacks)
Feb-02-24 07:00AM	Edwards EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve (Business Wire) +9.38%
06:27AM	Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment (MedTech Dive)
Feb-01-24 09:15AM	Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:44AM	Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength? (Zacks)
Jan-30-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024 (Business Wire)
06:15AM	4 heart device trends shaping the medtech sector in 2024 (MedTech Dive)
Jan-23-24 07:07AM	Edwards risks TAVR market share slip amid challenges from Abbott, Boston Scientific: survey (MedTech Dive)
Jan-19-24 11:26AM	What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? (Zacks)
Jan-16-24 01:20AM	Edwards Lifesciences Corporation (EW) Fell in Q4 Despite Double-Digit Revenue Growth (Insider Monkey)
Jan-03-24 07:40AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Jan-02-24 09:00AM	Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 05:24AM	Fears Of Negative Clinical Trial Result Dragged Edwards Lifesciences Corporation (EW) in Q3 (Insider Monkey)
Dec-14-23 07:49PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
Dec-11-23 12:27PM	Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook (Zacks)
Dec-08-23 05:11AM	Edwards to spin off its critical care business (MedTech Dive)
Dec-07-23 05:00PM	S&P 500 Gains and Losses Today: AI Excitement Powers AMD, Alphabet (Investopedia)
08:30AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Nov-26-23 05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-25-23 06:58AM	Could Ozempic Harm These 3 Medical Device Stocks? (Motley Fool)
Nov-24-23 11:31AM	Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-23-23 06:06AM	Here's Why You Should Retain Edward Lifesciences (EW) Stock Now (Zacks)
Oct-30-23 11:40AM	ITGR or EW: Which Is the Better Value Stock Right Now? (Zacks)
Oct-27-23 07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:15PM	Why Edwards Lifesciences Stock Plummeted Today (Motley Fool) -8.14%
03:06PM	CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION (PR Newswire)
02:00PM	TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION (PR Newswire)
11:33AM	Edwards Lifesciences Corporation (NYSE:EW) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:17AM	Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip (Zacks)
11:12AM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
07:23AM	Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E (Zacks)
07:20AM	Q3 2023 Edwards Lifesciences Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 06:00PM	Edwards Lifesciences Corp (EW) Reports Q3 Earnings: Sales Growth and New Therapy Approvals (GuruFocus.com)
06:00PM	Edwards Lifesciences (EW) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Edwards Lifesciences (EW) Q3 Earnings Match Estimates (Zacks)
04:32PM	Edwards Lifesciences: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences quarterly sales jump on robust demand for heart devices (Reuters)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Option Exercise	45.28	8,658	392,006	222,452	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Option Exercise	36.75	8,000	294,000	47,503	Dec 13 07:04 PM
MUSSALLEM MICHAEL A	Director	Dec 13 '23	Sale	74.62	29,350	2,190,043	4,486	Dec 13 07:04 PM
Wood Larry L	Global President TAVR & Surg	Dec 13 '23	Sale	71.86	8,658	622,164	213,794	Dec 13 07:04 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 13 '23	Sale	71.86	8,000	574,880	39,503	Dec 13 07:04 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Option Exercise	59.26	3,500	207,398	27,450	Dec 06 05:01 PM
Chopra Daveen	CVP, TMTT	Dec 06 '23	Sale	70.00	3,500	245,006	23,950	Dec 06 05:01 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Option Exercise	36.75	6,000	220,500	45,503	Nov 13 05:21 PM
Wood Larry L	Global President TAVR & Surg	Nov 13 '23	Sale	65.30	8,660	565,460	213,794	Nov 13 05:21 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '23	Sale	65.30	6,000	391,780	39,503	Nov 13 05:21 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Nov 06 06:33 PM
MUSSALLEM MICHAEL A	Director	Nov 03 '23	Sale	67.18	29,350	1,971,733	4,486	Nov 06 06:33 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Oct 31 05:22 PM
Ullem Scott B.	CVP, Chief Financial Officer	Oct 31 '23	Sale	62.66	7,255	454,569	19,248	Oct 31 05:22 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Option Exercise	45.28	8,660	392,096	222,454	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Option Exercise	36.75	5,000	183,750	44,503	Oct 13 05:01 PM
Wood Larry L	Global President TAVR & Surg	Oct 13 '23	Sale	70.00	8,660	606,198	213,794	Oct 13 05:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 13 '23	Sale	69.98	5,000	349,909	39,503	Oct 13 05:01 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Option Exercise	36.75	5,000	183,750	39,814	Oct 10 06:23 PM
Szyman Catherine M.	CVP, Critical Care	Oct 10 '23	Sale	72.68	5,000	363,400	34,814	Oct 10 06:23 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Option Exercise	59.26	8,500	503,682	32,450	Oct 03 04:58 PM
Chopra Daveen	CVP, TMTT	Oct 03 '23	Sale	70.00	8,500	595,000	23,950	Oct 03 04:58 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Oct 02 06:51 PM
MUSSALLEM MICHAEL A	Director	Oct 02 '23	Sale	68.84	29,350	2,020,454	4,486	Oct 02 06:51 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Option Exercise	36.75	7,255	266,621	26,503	Sep 29 04:49 PM
Ullem Scott B.	CVP, Chief Financial Officer	Sep 29 '23	Sale	69.54	7,255	504,527	19,248	Sep 29 04:49 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Option Exercise	45.28	8,660	392,096	222,454	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Sep 14 08:00 PM
Wood Larry L	Global President TAVR & Surg	Sep 14 '23	Sale	73.63	8,660	637,615	213,794	Sep 14 08:00 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 14 '23	Sale	73.71	4,500	331,695	39,503	Sep 14 08:00 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Option Exercise	36.75	5,000	183,750	39,814	Sep 08 05:29 PM
Szyman Catherine M.	CVP, Critical Care	Sep 08 '23	Sale	76.00	5,000	380,000	34,814	Sep 08 05:29 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Option Exercise	59.26	8,500	503,682	32,450	Sep 06 05:09 PM
Chopra Daveen	CVP, TMTT	Sep 06 '23	Sale	76.07	8,500	646,609	23,950	Sep 06 05:09 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Option Exercise	36.75	29,350	1,078,612	33,836	Sep 05 07:08 PM
MUSSALLEM MICHAEL A	Director	Sep 05 '23	Sale	75.86	29,350	2,226,491	4,486	Sep 05 07:08 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Option Exercise	36.75	7,255	266,621	26,503	Aug 31 05:34 PM
Ullem Scott B.	CVP, Chief Financial Officer	Aug 31 '23	Sale	77.79	7,255	564,366	19,248	Aug 31 05:34 PM
Chopra Daveen	CVP, TMTT	Aug 29 '23	Sale	76.69	1,500	115,040	23,950	Aug 29 05:31 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Option Exercise	45.28	6,421	290,722	220,215	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Option Exercise	36.75	4,500	165,375	44,003	Aug 14 06:02 PM
Wood Larry L	Global President TAVR & Surg	Aug 14 '23	Sale	79.30	6,421	509,185	213,794	Aug 14 06:02 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '23	Sale	79.30	4,500	356,850	39,503	Aug 14 06:02 PM
STONE HEISZ LESLIE	Director	Aug 10 '23	Sale	78.87	3,303	260,509	26,980	Aug 10 05:48 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Option Exercise	36.75	5,000	183,750	39,814	Aug 09 05:44 PM
Szyman Catherine M.	CVP, Critical Care	Aug 09 '23	Sale	78.64	5,000	393,185	34,814	Aug 09 05:44 PM

Open in Screener

NVST

Envista Holdings Corp

May 02 • 04:00PM ET

19.81

Dollar change +0.06
Percentage change 0.30	%

Healthcare • Medical Instruments & Supplies • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NVST Envista Holdings Corp daily Stock Chart

Held by: VTI IJH VB VBR VXF IHI IJJ SCHA DFAT VHT

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	0.49%	Shs Outstand	171.50M	Perf Week	-1.05%
Market Cap	3.40B	Forward P/E	13.74	EPS next Y	1.44	Insider Trans	2.33%	Shs Float	171.01M	Perf Month	-2.12%
Income	-120.40M	PEG	-	EPS next Q	0.31	Inst Own	105.82%	Short Float	5.48%	Perf Quarter	-16.55%
Sales	2.56B	P/S	1.33	EPS this Y	-17.37%	Inst Trans	0.03%	Short Ratio	3.91	Perf Half Y	-14.87%
Book/sh	24.09	P/B	0.82	EPS next Y	14.00%	ROA	-1.83%	Short Interest	9.37M	Perf Year	-47.13%
Cash/sh	5.52	P/C	3.59	EPS next 5Y	6.50%	ROE	-2.86%	52W Range	18.95 - 38.43	Perf YTD	-17.66%
Dividend Est.	-	P/FCF	13.03	EPS past 5Y	-	ROI	-2.14%	52W High	-48.45%	Beta	1.35
Dividend TTM	-	Quick Ratio	1.93	Sales past 5Y	-0.16%	Gross Margin	56.35%	52W Low	4.51%	ATR (14)	0.72
Dividend Ex-Date	-	Current Ratio	2.27	EPS Y/Y TTM	-152.89%	Oper. Margin	11.84%	RSI (14)	43.69	Volatility	5.60% 3.25%
Employees	12800	Debt/Eq	0.40	Sales Y/Y TTM	-0.08%	Profit Margin	-4.70%	Recom	2.69	Target Price	20.59
Option/Short	Yes / Yes	LT Debt/Eq	0.36	EPS Q/Q	-44.88%	Payout	-	Rel Volume	1.94	Prev Close	19.75
Sales Surprise	-1.77%	EPS Surprise	-17.70%	Sales Q/Q	-0.57%	Earnings	May 01 AMC	Avg Volume	2.39M	Price	19.81
SMA20	-1.20%	SMA50	-4.84%	SMA200	-21.50%	Trades		Volume	4,654,238	Change	0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-26-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$33 → $21
Feb-26-24	Initiated	Leerink Partners	Underperform	$19
Feb-09-24	Downgrade	Jefferies	Buy → Hold	$30 → $23
Feb-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Jan-05-24	Initiated	UBS	Neutral	$26
Dec-11-23	Downgrade	Goldman	Buy → Sell	$22
Nov-16-23	Initiated	Needham	Hold
Nov-02-23	Downgrade	Piper Sandler	Overweight → Neutral	$39 → $25
Aug-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$40 → $46
Jun-14-22	Downgrade	Robert W. Baird	Outperform → Neutral	$54 → $46
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$48
Oct-26-21	Upgrade	BofA Securities	Neutral → Buy	$49 → $48
Aug-05-21	Resumed	Credit Suisse	Outperform	$55
Jan-08-21	Upgrade	Credit Suisse	Neutral → Outperform	$31 → $41
Jun-16-20	Initiated	Piper Sandler	Neutral	$20
Dec-17-19	Resumed	Evercore ISI	Outperform	$35
Oct-14-19	Initiated	William Blair	Outperform
Oct-14-19	Initiated	Stifel	Buy	$34
Oct-14-19	Initiated	Robert W. Baird	Outperform	$33
Oct-14-19	Initiated	Morgan Stanley	Equal-Weight	$29

Show Previous Ratings

May-02-24 11:04AM	Envista Holdings Corporation (NYSE:NVST) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:54AM	Envista (NVST) Q1 Earnings Miss Estimates, Margins Down (Zacks)
09:16AM	Q1 2024 Envista Holdings Corp Earnings Call (Thomson Reuters StreetEvents)
03:45AM	Envista Holdings Corp (NVST) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-01-24 08:54PM	NVST Stock Earnings: Envista Holdings Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:30PM	Loading…
07:30PM	Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings (Zacks)
05:36PM	Envista Holdings Corp (NVST) Reports Mixed Q1 2024 Results, Misses Analyst EPS Estimates (GuruFocus.com)
05:25PM	Envista (NVST) Lags Q1 Earnings and Revenue Estimates (Zacks)
04:24PM	Envista: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Envista Reports First Quarter 2024 Results (PR Newswire)
Apr-26-24 06:50AM	Morgan Stanley Downgrades Envista Holdings to Equalweight From Overweight, Cuts Price Target to $21 From $33 (MT Newswires)
Apr-25-24 08:00AM	Buick, GMs low-key semi-luxury brand, is suddenly hot (CNN Business)
Apr-20-24 09:16AM	10 Best Healthcare Stocks to Buy Under $20 (Insider Monkey)
Apr-15-24 04:10PM	Envista Announces CEO Appointment (PR Newswire)
Apr-11-24 04:10PM	Envista Smile Project Donates $1.2 Million in 2023 (PR Newswire)
04:10PM	Loading…
Apr-04-24 04:10PM	Envista Schedules First Quarter 2024 Earnings Call (PR Newswire)
Mar-29-24 03:14AM	Multiple Reasons Led to the Fall of Envista Holdings Corporation (NVST) in Q4 (Insider Monkey)
Mar-19-24 11:35AM	DEXIS Enhances its Dental Implant Ecosystem with Intraoral Scanning Software Update - DEXIS IS ScanFlow (ACCESSWIRE)
09:00AM	DEXIS Announces AI Enhancements to Dental Implant Workflow Plus New Integration for 40,000+ Users (ACCESSWIRE)
Mar-14-24 10:24AM	Envista (NVST) Faces Macroeconomic Challenges, FX Headwind (Zacks)
Mar-13-24 05:16AM	Envista Holdings Corp. (NVST) Declined on Disappointing Earnings Results in Q4 (Insider Monkey)
Mar-08-24 11:30AM	Envista (NVST) Down 5.8% Since Last Earnings Report: Can It Rebound? (Zacks)
05:19AM	Do You Believe in the Positive Outlook of Insperity (NSP)? (Insider Monkey)
02:10AM	Here's Why Envista Holdings Corporation (NVST) Offers an Attractive Opportunity (Insider Monkey)
02:01AM	Is GoDaddy (GDDY) an Attractive Business? (Insider Monkey)
Feb-27-24 10:00AM	Buick shows off Wildcat EV in gold, debuts new brand tagline (Autoblog)
Feb-26-24 04:10PM	Envista Holdings Announces Planned CEO Succession Process (PR Newswire)
Feb-12-24 09:00AM	DEXIS Drives Dental Imaging Innovation with Introduction of AI-Powered Implant Ecosystem (ACCESSWIRE)
Feb-08-24 01:10PM	Q4 2023 Envista Holdings Corp Earnings Call (Thomson Reuters StreetEvents) -7.43%
10:12AM	Envista (NVST) Q4 Earnings Miss Estimates, Margins Down (Zacks)
10:10AM	Loading…
10:10AM	Envista Holdings Corporation (NYSE:NVST) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-07-24 08:00PM	Envista (NVST) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:00PM	Envista: Q4 Earnings Snapshot (Associated Press Finance)
04:41PM	Envista Holdings Corp (NVST) Faces Headwinds: A Look at Q4 and Full Year 2023 Results (GuruFocus.com)
04:10PM	Envista Reports Fourth Quarter and Full Year 2023 Earnings (PR Newswire)
Feb-06-24 09:15AM	Curious about Envista (NVST) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Jan-31-24 11:07PM	Envista Partners with Women in DSO to empower current and future generations of leaders in the dental industry (PR Newswire)
10:00AM	Earnings Preview: Envista (NVST) Q4 Earnings Expected to Decline (Zacks)
Jan-16-24 07:20PM	Envista to host Investor Event at the Envista Summit on February 16, 2024 (PR Newswire)
Jan-11-24 04:10PM	Envista Schedules Fourth Quarter 2023 Earnings Call (PR Newswire)
Dec-18-23 04:10PM	Envista Announces Participation in J.P. Morgan Healthcare Conference (PR Newswire)
Dec-14-23 04:10PM	Envista Holdings Corporation Appoints Three New Members to Leadership Team (PR Newswire)
Dec-11-23 03:27AM	Envista cut to Sell at Goldman Sachs, CRISPR to Underperform: 4 big analyst cuts (Investing.com)
Dec-01-23 11:32AM	Envista (NVST) Up 6.8% Since Last Earnings Report: Can It Continue? (Zacks) +5.33%
07:13AM	Artisan Partners Small Cap Fund Sold Envista Holdings Corporation (NVST) as It's an Ill-Timed Investment? (Insider Monkey)
Nov-22-23 11:43AM	15 Best Countries for Dental Implants (Insider Monkey)
Nov-21-23 03:51PM	Top 15 Countries With Best Dental Health (Insider Monkey)
Nov-15-23 06:26PM	Envista Announces Release of 2022 Sustainability Report (PR Newswire)
Nov-06-23 12:18PM	3 Stocks Primed to Get a Post-Halloween Lift (InvestorPlace)
Nov-02-23 03:05PM	Envista Holdings Corporation (NYSE:NVST) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.57%
10:50AM	Q3 2023 Envista Holdings Corp Earnings Call (Thomson Reuters StreetEvents)
10:24AM	Envista (NVST) Q3 Earnings Miss Estimates, Gross Margin Down (Zacks)
Nov-01-23 09:00PM	Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics (Zacks)
07:27PM	Envista Holdings Corp (NVST) Reports Q3 2023 Earnings with a Slight Increase in Core Sales (GuruFocus.com)
05:22PM	Envista: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Envista Reports Third Quarter 2023 Earnings (PR Newswire)
Oct-31-23 11:25AM	MedTech Stocks' Q3 Earnings Due on Nov 1: IDXX, EXAS & More (Zacks)
Oct-17-23 04:10PM	Envista Announces Participation in Jefferies London Healthcare Conference (PR Newswire)
Oct-12-23 09:00AM	DEXIS Announces Intraoral Scanner Software Integration with EasyRx (ACCESSWIRE)
Oct-05-23 04:10PM	Envista Schedules Third Quarter 2023 Earnings Call (PR Newswire) -5.00%
Sep-07-23 04:10PM	ENVISTA ANNOUNCES PARTICIPATION IN BAIRD GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
05:47AM	Heres Why Envista Holdings Corp. (NVST) Declined in Q2 (Insider Monkey)
Aug-30-23 04:57AM	Should You Consider Trimming Envista Holdings Corporation (NVST)? (Insider Monkey)
Aug-10-23 09:06AM	15 Highest Paying Countries for Dentists (Insider Monkey)
Aug-07-23 11:30PM	Envista Holdings Corporation Prices $435.0 Million Convertible Senior Notes Offering (PR Newswire)
07:15AM	Envista Holdings Corporation Announces Proposed Convertible Senior Notes Offering (PR Newswire)
Aug-04-23 12:08PM	Select Medical (SEM) Q2 Earnings Meet, Revenues Rise Y/Y (Zacks)
Aug-03-23 11:22AM	Envista (NVST) Q2 Earnings Top Estimates, Margins Expands (Zacks)
Aug-02-23 10:00PM	Envista (NVST) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:15PM	Envista (NVST) Beats Q2 Earnings and Revenue Estimates (Zacks)
05:08PM	Envista: Q2 Earnings Snapshot (AP Finance)
04:10PM	Envista Reports Second Quarter 2023 Earnings (PR Newswire)
Jul-26-23 04:10PM	Envista Smile Project Completes Second Oral Care Mission Trip to the Dominican Republic (PR Newswire)
10:02AM	Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Jul-23-23 11:44AM	11 Best Healthcare Stocks Under $50 (Insider Monkey)
Jul-06-23 04:10PM	Envista Schedules Second Quarter 2023 Earnings Call (PR Newswire)
Jul-04-23 09:19AM	Envista Holdings Corporation (NYSE:NVST) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
Jun-26-23 09:52AM	Envista (NVST) Gains From New Acquisitions Amid FX Woes (Zacks)
Jun-21-23 08:00PM	NVST: Raising target price to $35.00 (Argus Research)
Jun-15-23 09:00AM	DEXIS IOS Solutions Expands Its Portfolio and Ecosystem, Bringing New End-to-End Digital Workflows to Dental Practitioners (ACCESSWIRE)
May-29-23 08:14AM	Envista Holdings' (NYSE:NVST) three-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)
May-18-23 04:10PM	Envista Announces Participation in Stifel 2023 Jaws & Paws Conference (PR Newswire)
May-04-23 10:55AM	Envista (NVST) Q1 Earnings Miss Estimates, Margins Down (Zacks) -6.85%
10:38AM	Q1 2023 Envista Holdings Corp Earnings Call (Thomson Reuters StreetEvents)
May-03-23 05:35PM	Envista (NVST) Q1 Earnings and Revenues Miss Estimates (Zacks)
04:28PM	Envista: Q1 Earnings Snapshot (AP Finance)
04:10PM	Envista Reports First Quarter 2023 Earnings (PR Newswire)
Apr-29-23 09:11AM	Envista Holdings (NYSE:NVST) Has Some Way To Go To Become A Multi-Bagger (Simply Wall St.)
Apr-28-23 04:10PM	Envista Announces Participation in Bank of America 2023 Health Care Conference in Las Vegas (PR Newswire)
Apr-26-23 08:00PM	NVST: What does Argus have to say about NVST? (Argus Research)
Apr-13-23 08:28AM	What Makes Envista Holdings Corporation (NVST) a Good Investment Opportunity? (Insider Monkey)
Apr-06-23 11:32AM	A Look At The Intrinsic Value Of Envista Holdings Corporation (NYSE:NVST) (Simply Wall St.)
Apr-04-23 04:10PM	Envista Schedules First Quarter 2023 Earnings Call (PR Newswire)
Mar-15-23 04:15PM	Envista Concludes its North America Envista Summit 2023, Opens Registration for 2024 (PR Newswire)
Mar-14-23 02:59PM	At US$37.61, Is Envista Holdings Corporation (NYSE:NVST) Worth Looking At Closely? (Simply Wall St.)
Feb-11-23 07:06AM	Envista Holdings Corporation (NYSE:NVST) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-10-23 05:17AM	Envista Holdings Full Year 2022 Earnings: EPS Beats Expectations (Simply Wall St.)
Feb-08-23 06:25PM	Envista (NVST) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:15PM	Envista Reports Fourth Quarter 2022 Earnings (PR Newswire)
Feb-02-23 10:01AM	Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know (Zacks) +7.00%

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Conley Eric	SVP, Orthodontics	Nov 16 '23	Buy	22.89	2,185	50,015	47,376	Nov 20 05:49 PM
Nance Mark E	General Counsel	Nov 08 '23	Buy	21.75	5,000	108,750	39,042	Nov 09 04:18 PM
Aghdaei Amir	Chief Executive Officer	Nov 06 '23	Buy	21.53	10,000	215,253	295,362	Nov 07 04:23 PM
Keller Stephen	Principal Financial Officer	Nov 06 '23	Buy	21.53	2,000	43,060	13,070	Nov 07 04:18 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

EW

Edwards Lifesciences Corp

NVST

Envista Holdings Corp

Upgrade your FINVIZ experience